Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - PA: Institute of Genetics (Bridge Funding)

McGill University

$100,000.00

Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts (MLC), a paradigm for membrane protein quality control at multiple cellular locations

EF 2008-09

Résumé
Megalencephalic leucoencephalopathy with subcortical cysts (in short MLC) is a rare degenerative disease that primarily affects the brain white matter and is associated with impaired movements and cognitive functions. It is associates with genetic mutations in the MLC1 gene, identified in 1995. The MLC1 gene encodes a plasma membrane protein (MP) with a presently unknown function. Published and preliminary data suggest that mutations have at least two major consequences on the cellular fate of the MLC1 protein, contributing to its inability to accumulate in normal amount at the cell surface. Firstly, the mutant MLC1 cannot reach the cell surface efficiently and is trapped inside the cell. Secondly, if the mutant arrives to the cell surface it is very unstable due to rapid removal. The present proposal will use several cellular models in concert with genetic, biochemical and microscopic techniques to define the molecular-cellular mechanisms that compromise the mutant MLC1 arrival and retention at the cell surface. The results may identify novel drug targets that may alleviate the disease phenotype by helping to restore the mutant MLC1 expression and function at the cell surface.
Programme
Operating Grant - PA: Institute of Genetics (Bridge Funding)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
187540
Name
Lukacs Gergely L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts (MLC), a paradigm for membrane protein quality control at multiple cellular locations
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Institute of Genetics (Bridge Funding)
Keyworddelim
Conformational Disease; Er Degradation; Lysosomal Proteolysis; Protein Processing; Quality Control; Ubiquitination
Abstract
Megalencephalic leucoencephalopathy with subcortical cysts (in short MLC) is a rare degenerative disease that primarily affects the brain white matter and is associated with impaired movements and cognitive functions. It is associates with genetic mutations in the MLC1 gene, identified in 1995. The MLC1 gene encodes a plasma membrane protein (MP) with a presently unknown function. Published and preliminary data suggest that mutations have at least two major consequences on the cellular fate of the MLC1 protein, contributing to its inability to accumulate in normal amount at the cell surface. Firstly, the mutant MLC1 cannot reach the cell surface efficiently and is trapped inside the cell. Secondly, if the mutant arrives to the cell surface it is very unstable due to rapid removal. The present proposal will use several cellular models in concert with genetic, biochemical and microscopic techniques to define the molecular-cellular mechanisms that compromise the mutant MLC1 arrival and retention at the cell surface. The results may identify novel drug targets that may alleviate the disease phenotype by helping to restore the mutant MLC1 expression and function at the cell surface.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lukacs, Gergely L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~